Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative antigen processing pathways in anti-infective immunity

J Reimann1, S H Kaufmann

  • 1Department of Medical Microbiology and Hygiene, University of Ulm, D-89070, Ulm, Germany. jörg.reimann@medizin.uni-ulm.de

Current Opinion in Immunology
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Build-up and dephasing of Floquet-Bloch bands on subcycle timescales.

Nature·2023
Same author

Ultrafast electron dynamics in a topological surface state observed in two-dimensional momentum space.

Scientific reports·2023
Same author

TEMPORARY REMOVAL: VP.47 Interleukin 31 (IL-31) inhibition as a trigger for an immune-mediated myopathy?

Neuromuscular disorders : NMD·2022
Same author

Current production by non-methanotrophic bacteria enriched from an anaerobic methane-oxidizing microbial community.

Biofilm·2021
Same author

[Pain management in rare diseases].

Schmerz (Berlin, Germany)·2020
Same author

A 192-heme electron transfer network in the hydrazine dehydrogenase complex.

Science advances·2019
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Host immune cells process microbial antigens for T cell presentation via MHC class I pathways. Understanding these pathways is key for developing new vaccines targeting T cell responses against bacteria.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Exogenous antigens from microorganisms are processed by antigen-presenting cells (APCs) for presentation to T cells.
  • APC s like macrophages, B cells, mast cells, and dendritic cells utilize multiple pathways for antigen processing.
  • Conventional and nonconventional MHC class I and CD1 molecules are involved in presenting peptide and nonpeptide epitopes.

Purpose of the Study:

  • To explore emerging conceptual frameworks for processing and presenting bacterial epitopes to T cells.
  • To investigate the role of various antigen presentation pathways in antibacterial immunity.
  • To provide a basis for designing novel vaccines targeting T cell responses.

Main Methods:

  • Review of existing literature and conceptual frameworks.

Related Experiment Videos

  • Analysis of animal experimental data on T cell responses to bacterial antigens.
  • Focus on antigen processing and presentation via MHC class I and CD1 pathways.

    • Main Results:

    • Multiple pathways exist for APCs to process exogenous antigens for T cell presentation.
    • These pathways are crucial for generating protective T cell responses against bacteria.
    • Emerging frameworks highlight the role of conventional/nonconventional MHC class I and CD1 molecules.

    Conclusions:

    • Understanding antigen processing and presentation pathways is vital for antibacterial immunity.
    • These pathways are critical for the development of effective T cell-based vaccines.
    • Targeting MHC class I restricted T cell reactivity offers a promising strategy for vaccine design.